Table 1 Statistical analysis of patient characteristics in the intravenous to oral therapy and intravenous therapy groups
Intravenous to oral therapy group (n = 21) | Intravenous therapy group (n = 52) | p-value | |
|---|---|---|---|
Age (years) | 64 ± 19 | 65 ± 16 | 0.69 |
Male (n [%]) | 19 (90.5) | 40 (76.9) | 0.18 |
White blood cell count | 8.8 ± 3.8 | 10.6 ± 5.7 | 0.20 |
CRP | 6.9 ± 4.8 | 8.6 ± 6.7 | 0.20 |
Platelet count | 25.5 ± 9.7 | 23.2 ± 11.9 | 0.45 |
Indication (n [%]) | |||
Lower respiratory infection | 7 (33.3) | 13 (25.0) | 0.47 |
Skin, soft tissue, bone or joint infection | 7 (33.3) | 20 (38.5) | 0.68 |
Urinary/genital tract infection | 2 (9.5) | 3 (5.8) | 0.57 |
Intra-abdominal infection | 1 (4.8) | 2 (3.8) | 0.86 |
Other/unknown | 4 (19.0) | 14 (26.9) | 0.48 |